Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP628838.RAva9L-s_i6UNJQrlrTsxL08mL8ppvnehCe_m1ogMbk_s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP628838.RAva9L-s_i6UNJQrlrTsxL08mL8ppvnehCe_m1ogMbk_s130_assertion type Assertion NP628838.RAva9L-s_i6UNJQrlrTsxL08mL8ppvnehCe_m1ogMbk_s130_head.
- NP628838.RAva9L-s_i6UNJQrlrTsxL08mL8ppvnehCe_m1ogMbk_s130_assertion description "[PC-3 and LNCaP prostate carcinoma cell lines were transiently transfected with wild-type Egr-1 expression plasmid (pCMV-Egr-1) and treated with cisplatin and TPA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628838.RAva9L-s_i6UNJQrlrTsxL08mL8ppvnehCe_m1ogMbk_s130_provenance.
- NP628838.RAva9L-s_i6UNJQrlrTsxL08mL8ppvnehCe_m1ogMbk_s130_assertion evidence source_evidence_literature NP628838.RAva9L-s_i6UNJQrlrTsxL08mL8ppvnehCe_m1ogMbk_s130_provenance.
- NP628838.RAva9L-s_i6UNJQrlrTsxL08mL8ppvnehCe_m1ogMbk_s130_assertion SIO_000772 21617851 NP628838.RAva9L-s_i6UNJQrlrTsxL08mL8ppvnehCe_m1ogMbk_s130_provenance.
- NP628838.RAva9L-s_i6UNJQrlrTsxL08mL8ppvnehCe_m1ogMbk_s130_assertion wasDerivedFrom befree-20150227 NP628838.RAva9L-s_i6UNJQrlrTsxL08mL8ppvnehCe_m1ogMbk_s130_provenance.
- NP628838.RAva9L-s_i6UNJQrlrTsxL08mL8ppvnehCe_m1ogMbk_s130_assertion wasGeneratedBy ECO_0000203 NP628838.RAva9L-s_i6UNJQrlrTsxL08mL8ppvnehCe_m1ogMbk_s130_provenance.